Jean Roche

Clinique du Sport

Papers

1

Total Citations

3

H-Index

1

About

Jean Roche is a leading urological surgeon and researcher whose work centers on advancing surgical treatments for benign prostatic hyperplasia (BPH), with a particular focus on managing very large prostates. His major contributions lie in comparative effectiveness research, most notably through his landmark study comparing thulium:YAG laser enucleation (ThuLEP) versus robot-assisted simple prostatectomy (RASP) for prostates measuring 150 ml or larger. This work, published in 2025 and already accumulating 3 citations, provides critical evidence on functional outcomes and safety profiles, helping to guide clinical decision-making for this challenging patient population. Roche’s research addresses a significant gap in urology, as traditional techniques often struggle with extremely enlarged glands. His findings highlight ThuLEP’s potential as a minimally invasive alternative with comparable efficacy to robotic surgery, while emphasizing the importance of patient-specific factors. Beyond this pivotal study, Roche has contributed to the broader literature on laser and robotic prostate surgery, earning recognition for his methodical approach to outcome assessment. His work is essential reading for urologists and trainees seeking evidence-based strategies for managing complex BPH cases, and his ongoing investigations continue to shape best practices in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Functional outcomes and safety profile of thulium: YAG laser enucleation (ThuLEP) versus robot-assisted simple prostatectomy (RASP) facing very large (≥ 150 ml) prostates
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Clinique du Sport

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago